🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21486Original Research

Application of tissue clearing technology in a rat model of chronic spinal cord injury

WANG Zhizhuang¹,XU Bo¹,MA Guoliang¹,ZHANG Dan¹,QIN Xiaokuan¹,FENG Minshan¹,CHEN Xin¹,YANG Kexin¹,YANG Bowen¹,YIN He¹

Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China

Read Executive PreviewQuick FAQ
Application of tissue clearing technology in a rat model of chronic spinal cord injury
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1904, Issue 32 • pp. 100-112Citation:WANG Zhizhuang et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Tissue clearing technology enables high-resolution 3D visualization of neuronal morphology in chronic spinal cord injury, revealing soma atrophy, dendrite fragmentation, and axonal degeneration. • In a rat model of chronic spinal cord injury, tissue clearing combined with NeuN immunofluorescence clearly demonstrated structural disruption, including loss of gray matter layering and white matter integrity. • The technology provides a powerful tool to bridge the gap between functional deficits and structural pathology, offering a more comprehensive understanding of spinal cord injury mechanisms. • Tissue clearing technology holds promise for advancing preclinical research and therapeutic evaluation in spinal cord injury, though challenges remain for application in larger tissues.
Sponsored Research Highlight

Abstract

BACKGROUND: Studies have shown that tissue clearing technology enables the three-dimensional (3D) visualization of neurons in the spinal cord injury area, clearly presenting morphological changes of neurons, including soma atrophy, dendrite fragmentation, and axonal degeneration. OBJECTIVE: To systematically evaluate the application potential of tissue clearing technology in a rat model of chronic spinal cord injury. METHODS: Thirty-six female Sprague-Dawley rats were randomly and equally divided into a normal group (n=12), a sham surgery group (n=12), and a surgery group (n=12). The normal group received no treatment. The sham group underwent implantation and immediate removal of a poly(vinyl alcohol)/polyacrylamide interpenetrating network hydrogel into the C5-C7 spinal canal. The surgery group received implantation of the hydrogel to compress the spinal cord at C5-C7 to establish a chronic spinal cord injury model. At postoperative days 1, 3, 7, and 14, motor function was assessed using the Basso, Beattie, and Bresnahan (BBB) score and the modified Rivlin inclined plane test. At day 14, spinal cord tissue was harvested for hematoxylin-eosin staining to observe morphology, and tissue clearing combined with neuron-specific nuclear protein immunofluorescence labeling was used for three-dimensional reconstruction and cross-sectional view analysis. RESULTS AND CONCLUSION: (1) The BBB scores and inclined plane test angles in the surgery group were significantly lower than those in the normal and sham groups at all time points (P < 0.001). (2) Hematoxylin-eosin staining showed significant spinal cord injury in the surgery group, with swelling and destruction of nerve cells in the gray matter, loss of uniformity in white matter structure, disappearance of some nuclei, reduced cell number, massive glial cell proliferation and aggregation in the compression area, disordered white matter structure, and formation of numerous cavities. (3) Three-dimensional reconstruction and cross-sectional analysis of the spinal cord showed that in the normal and sham groups, the spinal cord appeared continuous and full, with uniform distribution of neuron-specific nuclear protein red fluorescence, dense layered arrangement of neurons in the anterior horn of the gray matter, and intact white matter fiber tracts. In the surgery group, the spinal cord appeared depressed or even interrupted, with significantly reduced fluorescence intensity of neuron-specific nuclear protein in the compressed segment, disrupted gray matter neuronal layer structure, and regional fluorescence interruption. These results indicate that tissue clearing technology can effectively display structural changes after spinal cord injury, providing strong support for studying the pathological mechanisms of spinal cord injury.

1. Introduction

Spinal cord injury (SCI) is typically triggered by an initial mechanical insult, followed by a cascade of pathophysiological processes that exacerbate the damage and lead to further neurological deterioration, resulting in temporary or permanent functional changes [1-2]. SCI is characterized by high morbidity, high disability rates, and a trend toward younger onset [3-5]. Globally, the incidence of SCI ranges from 10.4 to 83 cases per million population, with a rapidly increasing trend [6-9]. The pathological mechanisms of SCI are complex and difficult to repair, especially chronic compressive injury, which can lead to irreversible neuronal disconnection and disruption of neural circuits [10-12]. Traditional evaluation methods, such as behavioral scoring, can reflect functional deficits but fail to reveal the spatial heterogeneity of injury [13]. Histological staining can observe local morphological changes, but due to the limitations of two-dimensional sections, it cannot provide a panoramic view of three-dimensional structural damage [14-15]. This cognitive gap between structure and function severely restricts in-depth analysis of SCI mechanisms and precise assessment of therapeutic strategies.

In recent years, breakthroughs in tissue clearing technology have provided new approaches for neuroscience research [16-17]. Tissue clearing technology, combined with various fluorescence labeling techniques such as transgenic animals, viral tracing, fluorescent dyes, and in situ hybridization, enables the acquisition of three-dimensional structural information of biological tissues at the organ or even whole-body level [18]. By using chemical agents to eliminate light scattering in tissues, combined with immunolabeling and three-dimensional imaging, it achieves high-resolution, non-destructive visualization of intact organs [19]. The 'panoramic imaging' capability of tissue clearing technology allows researchers to break through the physical limitations of traditional two-dimensional sections and resolve long-distance neural projection trajectories, neuron-glia interaction networks, and spatial topological relationships of vascular-neural units at subcellular resolution [20]. In the field of musculoskeletal repair, tissue clearing technology helps improve the depth and resolution of bone and muscle research [21-22]. Studies have shown that tissue clearing technology enables dynamic observation of astrocytes and activated host anti-inflammatory microglia in promoting wound repair after spinal cord injury [23]. After SCI, neuronal survival, death, and neural circuit remodeling are key factors affecting functional recovery [24-25]. Tissue clearing technology can perform three-dimensional visualization of neurons in the injured area, clearly presenting morphological changes of neurons, including soma atrophy, dendrite fragmentation, and axonal degeneration.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
WANG Zhizhuang, XU Bo, MA Guoliang, ZHANG Dan, QIN Xiaokuan, FENG Minshan, CHEN Xin, YANG Kexin, YANG Bowen, YIN He (2026). Application of tissue clearing technology in a rat model of chronic spinal cord injury. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21486
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is tissue clearing technology?

Tissue clearing technology is a method that uses chemical or physical treatments to make biological tissues optically transparent, eliminating light scattering caused by refractive index mismatches (e.g., lipids, proteins). This enables high-resolution three-dimensional imaging of intact organs or even whole organisms.

How does tissue clearing technology benefit spinal cord injury research?

It allows three-dimensional visualization of neurons in the injured spinal cord, clearly showing morphological changes such as soma atrophy, dendrite fragmentation, and axonal degeneration. This provides a more comprehensive understanding of the structural damage and pathological mechanisms compared to traditional two-dimensional sections.

What were the main findings of this study?

The study demonstrated that tissue clearing technology effectively revealed structural changes in a rat model of chronic spinal cord injury, including disruption of gray matter layering, reduced neuronal fluorescence, and white matter disorganization. These findings support its potential for studying SCI pathology.

What are the limitations of tissue clearing technology?

The process is complex, requires multiple chemical reagents, and demands high operational standards. It may also cause some tissue damage, affecting accuracy. Additionally, it is currently mainly used in small animal models; application to larger tissues or human organs faces challenges such as poor clearing in thick tissues and imaging equipment limitations.

What is the significance of this research?

This research highlights tissue clearing technology as a powerful tool for three-dimensional structural analysis in spinal cord injury, bridging the gap between functional deficits and structural pathology. It offers new insights for understanding injury mechanisms and evaluating therapeutic interventions.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF